Suppr超能文献

氧化型低密度脂蛋白通过 LOX-1 介导的 MAPK/NF-κB 通路刺激树突状细胞成熟。

Oxidized low-density lipoprotein stimulates dendritic cells maturation via LOX-1-mediated MAPK/NF-κB pathway.

机构信息

Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, P.R. China.

出版信息

Braz J Med Biol Res. 2021 May 31;54(9):e11062. doi: 10.1590/1414-431X2021e11062. eCollection 2021.

Abstract

Dendritic cells (DCs) play a crucial role as central orchestrators of immune system response in atherosclerosis initiation and progression. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is involved in the immune maturation of DCs, but the underlying mechanisms remain unclear. We isolated mouse bone marrow progenitors and stimulated them with granulocyte-macrophage colony-stimulating factor and interleukin (IL)-4 to induce immature DCs. We then treated DCs with oxidized low-density lipoprotein (oxLDL) to induce maturation. LOX-1 siRNA was used to investigate the modulation of LOX-1 on the development of DCs and the underlying signal pathways. CD11c-positive DCs were successfully derived from mouse bone marrow progenitors. OxLDL promoted the expressions of DCs maturation markers and pro-inflammatory cytokines. OxLDL also upregulated LOX-1 expression and activated MAPK/NF-κB pathways. LOX-1 siRNA could attenuate the expression of MAPK/NF-κB pathways and inflammatory cytokines. In conclusion, oxLDL induced the maturation of DCs via LOX-1-mediated MAPK/NF-κB pathway, which contributed to the initiation and progression of atherosclerosis.

摘要

树突状细胞(DCs)在动脉粥样硬化的发生和发展中作为免疫系统反应的核心调控者发挥着至关重要的作用。凝集素样氧化型低密度脂蛋白受体-1(LOX-1)参与 DCs 的免疫成熟,但潜在机制尚不清楚。我们分离了小鼠骨髓祖细胞,并使用粒细胞巨噬细胞集落刺激因子和白细胞介素(IL)-4 刺激它们诱导未成熟的 DCs。然后,我们用氧化型低密度脂蛋白(oxLDL)处理 DCs 以诱导成熟。使用 LOX-1 siRNA 来研究 LOX-1 对 DC 发育的调节及其潜在的信号通路。成功从小鼠骨髓祖细胞中衍生出 CD11c 阳性 DCs。oxLDL 促进了 DCs 成熟标志物和促炎细胞因子的表达。oxLDL 还上调了 LOX-1 的表达并激活了 MAPK/NF-κB 通路。LOX-1 siRNA 可以减弱 MAPK/NF-κB 通路和炎症细胞因子的表达。总之,oxLDL 通过 LOX-1 介导的 MAPK/NF-κB 通路诱导 DCs 的成熟,这有助于动脉粥样硬化的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f0/8186376/5d6bab563a2b/1414-431X-bjmbr-54-9-e11062-gf001.jpg

相似文献

引用本文的文献

2
Dendritic cells immunotargeted therapy for atherosclerosis.树突状细胞免疫靶向治疗动脉粥样硬化
Acta Pharm Sin B. 2025 Feb;15(2):792-808. doi: 10.1016/j.apsb.2024.12.029. Epub 2024 Dec 31.

本文引用的文献

4
Immunity and Inflammation in Atherosclerosis.动脉粥样硬化中的免疫与炎症。
Circ Res. 2019 Jan 18;124(2):315-327. doi: 10.1161/CIRCRESAHA.118.313591.
10
Dendritic cells in atherosclerosis: evidence in mice and humans.动脉粥样硬化中的树突状细胞:小鼠和人类的证据
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):763-70. doi: 10.1161/ATVBAHA.114.303566. Epub 2015 Feb 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验